Skip to main content

Table 3 Risk of a subsequent exacerbation of patients with ≥1 exacerbation during the 12-month after a previous exacerbation

From: The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA

  

US database

UK database

  

N = 27,865

N = 17,785

 

Covariates

HR (95% CI)a

HR (95% CI)b

Exacerbation type

OCS only

Ref.

Ref.

ED/hospitalization

1.35 (1.26, 1.44)

1.32 (1.18, 1.47)*

Exacerbations during the 12-month pre-index period

0

NR

Ref.

≥1

NR

1.90 (1.75, 2.05)*

GINA (US only) or BTS (UK only) Treatment Stepsc

Step 1

Steps 1–3 combined: Ref.

Ref.

Step 2

1.02 (0.90, 1.17)

Step 3

1.35 (1.19, 1.53)*

Step 4

1.26 (1.18, 1.35)

1.44 (1.25, 1.65)*

Step 5

1.44 (1.32, 1.56)

1.87 (1.64, 2.14)*

Not classifiable/none

0.76 (0.34, 1.69)

1.36 (0.85, 2.19)

  1. *p < 0.0001
  2. aMultivariable proportional hazards model with the following covariates: exacerbation type, gender, GINA Step, Leidy category
  3. bmultivariable proportional hazards model with the following covariates: exacerbation type, gender, BTS Step, atopy, Leidy category and exacerbation history; cGINA failed the proportionality test so was removed from the UK database
  4. BTS British Thoracic Society, CI confidence interval, ED emergency department, GINA Global Initiative for Asthma, HR hazard ratio, NR not referenced, OCS oral corticosteroids